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elderly are limited in literature. This study, therefore, aimed to evaluate the pre-
scription pattern specifically among Indian elderly patients using WHO prescrib-
ing indicators.
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Objectives: The aim of this study is to determine the main causes of the dynamics 
of outpatient drug expenditures in Austria on an aggregate view (ATC level 1) over 
the last 10 years and to identify the key factors for the current developments at a 
more detailed, therapeutic level. MethOds: The data comprise the filled prescrip-
tions at the expense of all statutory health insurance funds in Austria, covering 
more than 97% of the national population. Observation period is from 2005 to 2014, 
with a preview of 2015. Year-on-year changes are calculated at different ATC levels. 
Costs are in euros excluding VAT. Results: Pharmaceutical expenditures increased 
significantly from 2005 until 2008, while from 2009 to 2013 there were only moderate 
increases. In 2014, expenditures started to rise considerably again, the ATC groups J 
(antiinfectives), L (antineoplastics and immunomodulators), and B (blood and blood 
forming organs) practically being the sole causes. One steady development over 
the last 10 years is the constant cost increase in the group L. Group N (nervous 
system) was the second cost driver until 2011, but faded afterwards. Beginning 
with 2012, group B is one of the major cost drivers. There are recently no significant 
cost declines through losses of exclusivity, except for the year 2013. Looking more 
into detail, one can observe that the current rise is strongly dominated by the new 
hepatitis c drugs (part of group J), followed by direct oral anticoagulants (DOACs, 
part of group B). cOnclusiOns: The new hepatitis c drugs are the main cause for 
the current increases in public outpatient pharmaceutical expenditures in Austria. 
As there are no remarkable compensating savings via generic entries, the cost rise 
poses a severe challenge for the public health insurance system, especially amid 
continuing weak economic growth and therefore stressed health budgets.
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Objectives: To assess drug use pattern in outpatient departments (OPDs) 
of two tertiary care hospitals (Bahawal Victoria Hospital and Civil Hospital) of 
Bahawalpur, Pakistan. MethOds: This was a descriptive, non-experimental and 
cross-sectional study. For the prescribing indicators, 2,400 prescriptions (10 OPDs 
per hospital, 120 prescriptions per OPD) were systematically sampled out of the 
total 1,560, 000 prescriptions written during April 2014 to March 2015. A total of 600 
randomly selected patients (300 patients per hospital, 30 per OPD) and all pharma-
cists available in both hospitals were interviewed to investigate the patient-care 
and facility-specific indicators. We used published ideal standards for each of the 
WHO/INRUD indicators. Results: Among the prescribing indicators, the average 
number of drugs per encounter was 2.8 (SD = 1.3) (optimal value = 1.6–1.8), the 
drugs prescribed by generic name were 56.6% (optimal value = 100%), the encoun-
ters with an antibiotic prescribed were 51.5% (optimal value = 20.0–26.8%), the 
encounters with an injection prescribed were 0.0% (optimal value = 13.4–24.1%) 
and the drugs prescribed from Essential Drugs List (EDL) were 98.8% (optimal value 
= 100%). Among the patient-care indicators, the average consultation time was 
1.2 minutes (SD = 0.8) (optimal value ≥ 10 minutes), the average dispensing time 
was 8.7 seconds (SD = 4.9) (optimal value ≥ 90 seconds), the percentage of drugs 
actually dispensed was 97.3% (optimal value = 100%), the percentage of drugs 
adequately labeled was 97.3% (optimal value = 100%) and the patients’ knowledge 
of correct dosage was 61.6% (optimal value = 100%). Among the facility-specific 
indicators, both health care facilities had a copy of EDL and key drugs available 
in the stock were 72.4% (optimal value = 100%). cOnclusiOns: Irrational use of 
drugs was observed in both health care facilities. Continuous education of the 
physicians, increased physician-to-patient and pharmacist-to-patient ratio are 
some options to promote rational drug use.
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Objectives: Systematic literature reviews (SLRs) play an important role in 
evidence-based medicine and are increasingly favored over traditional narra-
tive reviews as a method to objectively summarize vast amounts of outcomes 
data. Our objective was to evaluate a cross-section of published SLRs in oncol-
ogy and determine the top journals, main purposes, meta-analysis frequency, 
and sponsorship. MethOds: Searches were conducted in Embase and MEDLINE 
for the year 2014 and further restricted to cancer topics. Case reports, editori-
als, conference abstracts, and letters were excluded. Abstracts were manually 
reviewed to identify SLRs, published in journals, and reporting oncology drug 
therapy. Results: A total of 1,510 unique citations were identified; 727 were 
determined to be SLRs in oncology. 9 SLRs included case reports describing rare 
cancers or adverse drug reactions. Drug therapy was noted in 391 publications 
(53.8%); 210 included meta-analysis. Journals publishing the largest number of 
SLRs were PLoS ONE (n= 30), Tumor Biology (n= 17), Cancer Treatment Reviews 
(n= 15), World Journal of Gastroenterology (n= 10) and Journal of Clinical Oncology 
(n= 9). Impact factors for these journals ranged from 2.369 to 17.879. Most fre-
quent purposes were treatment comparisons (27.9%), efficacy assessments (15.6%), 
17%). Considering the disease treatment distribution, 857 patients were treated for 
rheumatoid arthritis (28,55%), 811 for psoriatic arthritis (27,02%), 421 for psoria-
sis (14,02%) and remaining patients for other diseases (i.e. ankylosing spondylitis, 
ulcerative colitis) . 86 patients (25.8%) switch biologic therapy within the first 120 
days, 97 patients (29.22%) between 120 and 210 days, 82 patients (24.70%) between 
210 and 300 days, 67 patients (20, 18%) between 300 and 365 days. cOnclusiOns: 
The present study is able to provide a map of the current strategy of treatment 
with biologics in the region Lazio considering medical conditions and prescribed 
treatments.
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Objectives: To understand the full impact of a novel treatment, particularly in 
more subjective symptoms such as pain, capturing information on any additional 
medication a patient may have taken alongside the study drug is vital. Two major 
challenges to the accurate recording of this data in global clinical trials have been 1) 
producing “localisations” of concomitant medications that are applicable and com-
parable in all countries involved in the study; and 2) moving away from a reliance on 
retrospective, site-based capture from patients. The aim of this study was to develop 
and document an easy to use electronic diary solution combined with an appropri-
ately localised medication list. MethOds: An electronic medication diary which 
allowed for the recording of medication name, route of administration and dosage 
was developed for a handheld platform, with iterative testing and refinement in 
users. The solution included a pre-populated, tailored list of the patient’s most com-
mon drugs (n = 38), which could be localised on a country-by-country basis (n = 21) 
following a process for ensuring the appropriateness of the drug name in the local 
market. Results: The iterative approach to design and development ensured the 
development of an electronic solution which was user-friendly and intuitive. Over 
3 rounds of testing a number of updates were made based on feedback from user 
relating to the flow of the diary and the training module. Best practice for developing 
appropriate localised list of concomitant medication involved asking two local 
experts for feedback using in-country medical databases. cOnclusiOns: Accurate 
tracking of concomitant medication usage is an important aspect of assessing the 
effectiveness of a new treatment. A user-focused electronic diary solution over-
comes the limitations of traditional, retrospective approaches to capturing this 
information. Localisation of the concomitant drug list ensures accurate and com-
parable data captured across all studies in a trial.
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Objectives: This study aimed to evaluate the Prevalence and Perception Use of 
Non-Prescription medicines (NPM) among medical undergraduate students (i.e. 
from pharmacy, MBBS and nursing students) in Quetta, Pakistan. MethOds: A 
cross-sectional study was conducted by using self-administered questionnaire, 
which consists of 15 questions. Medical students i.e. pharmacy, MBBS and nursing 
students were included in the study from different institutes providing the medi-
cal education. he descriptive statistics (frequencies and percentage) was used to 
present the data . All analyses were performed using SPSS 20.0. Results: A total 
of 300 questionnaires were distributed and 260 were returned (Response rate of 
86.7%). Among 260 respondents females were 164 (63.1%). Majority of participants 
246 (94.6%) knew about Non-Prescription medicines (NPM), 240 (92.3%) were used 
NPM drugs and 228 (87.7%) purchases NPM easily form the pharmacies. one hundred 
and forty (53.8%) respondents know about contraindication of NPM drugs while 205 
(78.8%) recommended the use of NPM to friend and relatives. The major use of NPM 
is to relief ache, pain and other condition such as cough, cold, fever, diarrhea, dys-
menorrhea constipation, vomiting and flu etc. cOnclusiOns: This study showed 
that majority of the Medical students were aware of different non-prescription 
medicines and their use and high prevalence is present among medical student to 
use these NPM for minor illness.
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Objectives: Studies on the characterization of prescription among Indian elderly 
are limited in literature. This study, therefore, aimed to evaluate the prescription 
pattern specifically among Indian elderly patients using WHO prescribing indi-
cators. MethOds: Prescriptions of 4005 outpatients, age 60 yrs or above, were 
evaluated prospectively using WHO prescribing indicators. Results: The aver-
age age (±SEM) of patients was 68.28±0.11 yrs. On an average, each patient had 
2.01±0.01 diagnoses & was prescribed 6.45±0.04 drugs. The most common disorder 
was ‘Diseases of circulatory system”. The patients were prescribed an average of 
6.45±0.04 medications. Over half of the patients (57.9%) received more than five 
medications concurrently. The percentage of drugs prescribed by generic name 
was only 0.8%. Antibiotic usage was 13% while 7.3% of patients were prescribed 
injections. The percentage of drugs prescribed from National List of Essential 
Medicines 2003 was 66% of the drugs prescribed. cOnclusiOns: The minimal 
prescription of antimicrobials and injections coupled with higher prescriptions 
from essential drug list is a very positive reflection of good prescribing among 
elderly outpatients. Studies on the characterization of prescription among Indian 
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surgery was obtained. a total of 325 records were include in the study. Appendicitis 
was most common cause of admission (N= 124, 40.6%). Most of the patients (N= 
209, 68.5%) hospitalized for maximum of 4 days in hospitals after surgery. Most 
commonly prescribed antibiotics were Ceftriaxone, Metronidazole and Gentamicin. 
Cases of multiple antibiotic in treatment were high, in which triple antibiotics con-
taining treatments were leading (N= 220, 72%) followed by double antibiotics con-
taining treatments (N= 85, 28%). cOnclusiOns: The study revealed that there was 
high number of antibiotics prescribed to the post operative patients irrationally, as 
there is no evidence for the prescription of these antibiotics. Antibiotics are pre-
scribed in multiple forms. There is strong need of a local Guidelines to be established 
for use of antibiotics rationally.
HealtH care use & Policy stuDies – equity and access
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Objectives: China is far behind the international standard in health equity. The 
main purpose of this paper is to evaluate the equity of health services utilization 
of rural residents in western China and analyze its influencing factors, thus raising 
policy suggestions to improve the equity of health system. MethOds: Related 
data on health services utilization of rural residents were collected through ran-
dom-sampling household surveys. Based on the standardized variable of Health 
Need, the parallel equity of rural residents’ health service utilization is assessed 
by calculating Concentration Index (CI) and mean-value and difference testing 
among residents of different income levels, while the vertical equity is evalu-
ated by calculating Index of Dissimilarity (ID) among residents of different ages. 
Besides, Two-step Model is adapted to analyze its influencing factors. Results: 
On outpatient service utilization, Standard CI of two-week outpatient visiting 
rate, two-week outpatient visiting times and outpatient expenditure are 0.1048, 
0.1213 and 0.5178 respectively, while ID of the three indexes mentioned above are 
0.054719, 0.056134 and 0.011823 respectively (P< 0.05). On inpatient service utiliza-
tion, Standard CI of annual hospitalization rate, annual hospitalization times, days 
of hospitalization, inpatient expenditure and its compensation level are 0.07914, 
0.0543, -0.098, 0.3012 and 0.1740 respectively, while ID of the five indexes men-
tioned above are 0.053098, 0.06122, 0.308912, 0.316444 and 0.379235 respectively 
(P< 0.05). Health status, financial ability, educational level and marital status have 
significant influence on health service utilization equity. cOnclusiOns: Parallel 
inequity of health service utilization of rural residents of different income lev-
els exits in outpatient expenditure, inpatient expenditure and its compensation 
level, while vertical inequity of rural residents of different ages exits in days of 
hospitalization, inpatient expenditure and its compensation level. Comprehensive 
measures should be considered to alleviate the inequity of health service utiliza-
tion in rural residents who live alone, come from less well-off families and have 
poorer health, lower educational levels.
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Objectives: Data on health services utilization of urban residents collected 
through random-sampling household surveys are analyzed to access the equity of 
health service utilization of urban residents in western China. MethOds: Variable 
of Health Need of urban residents is standardized through Logistic Model, Negative 
Binomial Model and Possion Model. Residents are divided into 5 groups by per 
capita annual income in families, and parallel equity of health service utilization 
is assessed by calculating Concentration Index (CI) and mean-value and difference 
testing among residents of different income levels. While residents are divided into 8 
groups by ages, and vertical equity is evaluated by calculating Index of Dissimilarity 
(ID) among residents of different ages. Results: On outpatient service utilization, 
Standard CI of two-week outpatient visiting rate, two-week outpatient visiting times, 
outpatient expenditure and its compensation level are -0.0040, -0.0115, 0.0244, 0.2356 
respectively, while ID of the four indexes mentioned above are 0.2709 (P< 0.05), 0.3285 
(P< 0.05), 0.3434 (P< 0.05), 0.3785 (P= 0.5489) respectively. On inpatient service utiliza-
tion, Standard CI of annual hospitalization rate, annual hospitalization times, days of 
hospitalization, inpatient expenditure and its compensation level are 0.1110, 0.0200, 
0.0260, 0.0336 and 0.1449 respectively, while ID of the five indexes mentioned above 
are 0.3139, 0.3408, 0.3814, 0.4397, 0.4691 respectively (P< 0.05). cOnclusiOns: Equity 
of outpatient service utilization is poor in that urban residents with low-income or 
over the age of 65 get fewer outpatient compensation fees, while equity of hospitali-
zation service utilization is weak in that low-income urban residents use fewer hos-
pitalization services and get less hospitalization compensation fees, and that urban 
residents over the age of 65, who is in most health service demand, can neither get 
the most hospitalization services nor receive a higher proportion of hospitalization 
compensation. Comprehensive measures should be taken to improve the equity of 
health service utilization in urban residents who are old-aged or come from less 
well-off families.
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Objectives: The factors which determine health services utilization (HSU) and 
access to health services are at the epicentre of health policy discussions, in an 
and adverse event investigations (14.6%). Foremost cited products were bevaci-
zumab and sorafenib. Sponsorship was independent (43.4%), not reported (28.7%), 
industry (6.6%), or inaccessible at time of assessment (21.3%). Many SLRs were 
from China. cOnclusiOns: In our analysis, PLoS ONE published the most SLRs. 
Journals offering open access are attracting a growing number of SLRs and many 
boast a diverse readership. A significant body of work is emerging from China 
where, as in the rest of the world, the majority of SLRs appear to be independently 
sponsored. SLRs are valued by clinical, payer, and regulatory decision-makers, 
since they provide a convenient synthesis of available evidence to address knowl-
edge gaps and facilitate translation of research into practice.
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Objectives: Few studies have been conducted on vitamin dispensing patterns 
in retail pharmacies in South Africa. The aim of this study was to analyse the dis-
pensing patterns of vitamins (ATC group A11) over a one year period in a group of 
community pharmacies in South Africa. MethOds: A retrospective drug utilisa-
tion study was conducted on community pharmacy electronic dispensing records 
in South Africa for 2013. All products in ATC subgroup A11 were extracted and 
analysed. Results: A total of 164 233 vitamin products were dispensed to 84 805 
patients. Most patients were females (62.64%) and most of the vitamin products 
(59.62%) were dispensed to females. Males received on average 2.09 (SD= 2.63) 
vitamin products per year, compared to 1.84 (SD= 2.13) products for females. 
Ergocalciferol (A11CC01) was the most often dispensed (37.48% of all vitamin 
products), followed by plain Vitamin B-complex products (A11EA00) accounting for 
32.77%. Ergocalciferol is only available on prescription in South Africa (50 000 IU tab-
lets or 50 000 IU/ml oily drops). The tablets are relatively inexpensive (approximately 
R2.50 per tablet). Of all the dosage formulations, tablets were preferred (62.84% of 
all vitamin products). Most injections were for Vitamin B1 or Vitamin B combina-
tion products. Vitamin B injections have recently been rescheduled in South Africa 
to prescription-only products and consumers therefore no longer can buy these 
products from a pharmacy or ask the pharmacist to administer a Vitamin B injection 
without a prescription. The number of vitamin products dispensed increased stead-
ily over the year. cOnclusiOns: Vitamins are important in treating nutritional 
deficiencies, yet few studies on vitamins have been conducted in pharmacies. It is 
expected that the change in the over-the-counter availability of Vitamin B injec-
tions in South Africa will impact on their dispensing and usage patterns. It will be 
important to monitor the effect that this change in prescribing status will have on 
vitamin sales in pharmacies.
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Objectives: Substitution has been implemented for generics in most markets 
and very often resulted in high uptake correlated with fast and strong price ero-
sion. Although biosimilars and generics are different, the low biosimilar penetra-
tion in most of Europe prompted some countries to discuss the implementation 
of substitution for biosimilars as an initiative to quickly reduce healthcare spend-
ing by boosting their uptake. The objective of this study was to identify initiatives 
undertaken worldwide with regards to biosimilar substitution and their potential 
implications. MethOds: A literature review was conducted from European and 
national health authorities’ websites, Generics and Biosimilars Initiative website, 
Medline® database, and available grey literature. Results: In Europe, European 
Medicines Agency leaves substitution responsibility to national regulators. Sixteen 
EU Member States have either law or guidelines prohibiting automatic biosimi-
lar substitution. In 2013, France became the first European country to pass a law 
for biosimilar substitution. In 2014, Norwegian government set up a clinical study 
to assess interchangeability of Remicade® (infliximab) and its biosimilar. In the 
United-States, the Food and Drug Administration has the authority to designate a 
biosimilar as interchangeable but substitution is then regulated at state level. Thirty 
one states have currently considered legislation establishing standards for biosimi-
lar substitution. In Canada, interchangeability remains a provincial decision. So far, 
one province positioned against substitution. The Pharmaceutical Benefits Advisory 
Committee in Australia recently considered marking biosimilar as equivalent to 
reference product, which would allow substitution at pharmacy level. In South 
Korea, Japan and South Africa automatic substitution is prohibited at pharmacy 
level. cOnclusiOns: In most countries, the choice of treatment with a reference 
biologic or with a biosimilar remains a clinical decision entrusted to the prescrib-
ing physician. Enhancing substitution may increase the penetration of biosimilars 
which constitutes an additional therapeutic option available to practitioners.
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Objectives: Present study is conducted to determine the trend and use of antibi-
otics among the post-operative patients of tertiary care hospital. MethOds: The 
present study was designed as retrospective study. The data was obtained from 
the records of tertiary care hospital (Bolan Medical complex Hospital). The data 
was gathered randomly from the record for the period between July to October, 
2015. Information regarding antibiotic use along patient related data was obtained. 
The collected data was reviewed, coded, verified and statistically analyzed using 
SPSS. Results: Data from the patients, who has been prescribed antibiotic after 
